ECSP993070A - HIGH-AFFINITY LEAGUES FOR THE NOCICEPTINE ORL 1 RECEPTOR - Google Patents

HIGH-AFFINITY LEAGUES FOR THE NOCICEPTINE ORL 1 RECEPTOR

Info

Publication number
ECSP993070A
ECSP993070A ECSP993070A ECSP993070A EC SP993070 A ECSP993070 A EC SP993070A EC SP993070 A ECSP993070 A EC SP993070A EC SP993070 A ECSP993070 A EC SP993070A
Authority
EC
Ecuador
Prior art keywords
alkyl
aryl
optionally substituted
heterocycloalkyl
heteroaryl
Prior art date
Application number
Other languages
Spanish (es)
Inventor
John A Hey
Deen Tulshian
Ginny D Ho
Lisa S Silverman
Julius J Matasi
Robbie L Mcleod
Richard W Chapman
Ana Bercovici
Francis M Cuss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993070 priority Critical patent/ECSP993070A/en
Publication of ECSP993070A publication Critical patent/ECSP993070A/en

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nuevos compuestos de fórmula (gráfico), o una sal o solvato de los mismos, farmacéuticamente aceptable en los cuales: la linea de puntos representa un doble enlace opcional; X1 es H, alquilo, cicloalquilo, arilo, heteroarilo, heterocicloalquilo o heterociclilo benzofusionado opcionalmente sustituidos; X2 es H, -CH=, -CN, amino, alquilo o arilo opcionalmente sustituido; o X1 o X2 conjuntamente forman un grupo espiro heterociclilo opcionalmente benzofusionado. R1, R2, R3 y R4 son independientemente H o alquilo, o (R1 y R4) o (R2 y R3) o (R1 y R3) o (R2 y R4) conjuntamente pueden formar un puente alquileno de 1 a 3 átomos de carbono; Z1 es alquilo, arilo, heteroarilo, cicloalquilo o heterocicloalquilo opcionalmente sustituido o -CO2(alquilo o amino substituido) o CN, Z2 es H o Z1; Z3 es H o alquilo; o Z1, Z2 y Z3 conjuntamente con el carbon al cual están unidos forman anillos biciclicos saturados o insaturados; composiciones farmacéuticas que incluyen los mismos y el uso de dichos compuestos como inhibidores, receptores de nociceptina útiles para el tratamiento, ansiedad, tos, asma, depresión y abuso de alcohol.Novel compounds of formula (graph), or a pharmaceutically acceptable salt or solvate thereof in which: the dotted line represents an optional double bond; X1 is optionally substituted H, alkyl, cycloalkyl, aryl, heteroaryl, heterocycloalkyl or heterocyclyl; X2 is H, -CH =, -CN, amino, alkyl or optionally substituted aryl; or X1 or X2 together form an optionally benzofused spiro heterocyclyl group. R1, R2, R3 and R4 are independently H or alkyl, or (R1 and R4) or (R2 and R3) or (R1 and R3) or (R2 and R4) together can form an alkylene bridge of 1 to 3 carbon atoms ; Z1 is optionally substituted alkyl, aryl, heteroaryl, cycloalkyl or heterocycloalkyl or -CO2 (alkyl or substituted amino) or CN, Z2 is H or Z1; Z3 is H or alkyl; or Z1, Z2 and Z3 together with the carbon to which they are attached form saturated or unsaturated bicyclic rings; Pharmaceutical compositions including the same and the use of said compounds as inhibitors, nociceptin receptors useful for the treatment, anxiety, cough, asthma, depression and alcohol abuse.

ECSP993070 1999-07-26 1999-07-26 HIGH-AFFINITY LEAGUES FOR THE NOCICEPTINE ORL 1 RECEPTOR ECSP993070A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993070 ECSP993070A (en) 1999-07-26 1999-07-26 HIGH-AFFINITY LEAGUES FOR THE NOCICEPTINE ORL 1 RECEPTOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993070 ECSP993070A (en) 1999-07-26 1999-07-26 HIGH-AFFINITY LEAGUES FOR THE NOCICEPTINE ORL 1 RECEPTOR

Publications (1)

Publication Number Publication Date
ECSP993070A true ECSP993070A (en) 1999-09-09

Family

ID=42044057

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993070 ECSP993070A (en) 1999-07-26 1999-07-26 HIGH-AFFINITY LEAGUES FOR THE NOCICEPTINE ORL 1 RECEPTOR

Country Status (1)

Country Link
EC (1) ECSP993070A (en)

Similar Documents

Publication Publication Date Title
CO5080744A1 (en) HIGH AFFINITY LINKS FOR THE NOCICEPTINE RECEIVER ORL-1
UY25142A1 (en) CCR-3 RECEPTOR ANTAGONISTS
PE20010397A1 (en) QUINUCLIDINE DERIVATIVES AS ANTAGONISTS OF MUSCARINE M3 RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR051090A1 (en) HETEROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF ESTEAROIL-COA DESATURASA
AR063331A1 (en) DERIVATIVES OF BIARIL ETER UREA AND PHARMACEUTICAL COMPOSITIONS
AR051094A1 (en) HETEROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF ESTEAROIL-COA DESATURASA
AR074814A1 (en) PYRIMIDINES REPLACED AS ANTAGONISTS OF THE CCR2 RECEIVER AND USES OF THE SAME IN MEDICINES.
ECSP034475A (en) DERIVATIVES OF 4-PHENYL-PIRIDIN AS ANTAGONISTS OF THE NEUROQUININE RECEIVER-1
AR051461A1 (en) PIRAZOLO COMPOUND [1,5-A] PIRIMIDIN-7-IL-AMINA POLYFORM FORM 1 OF [3- (4-METOXI-2-METHYL-PHENYL) -2,5-DIMETIL-PIRAZOLO [1,5-A] PIRIMIDIN-7-IL] - [(S) -1- (3-METHYL- [1,2,4] OXADIAZOL-5-IL) -PROPIL] -AMINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE IT
AR036093A1 (en) COMPOUNDS DERIVED FROM TIAZOLIDINILO, PIRROLIDINILO, OXAZOLIDINILO, PIPERIDILO, MORFOLINILO AND TIOMORFOLINILO, ITS USE, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, AND INTERMEDIARY COMPOUNDS
AR051202A1 (en) HETEROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF ESTEAROIL-COA DESATURASA
UY27336A1 (en) 4-PIPERACINYLINDOL DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY
YU74694A (en) MORPHOLIN AND THIOMORPHOLIN TAHIKININ RECEPTOR ANTAGONISTS -
AR051091A1 (en) HETEROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF ESTEAROIL-COA DESATURASA
PE20030865A1 (en) PHARMACEUTICAL COMPOSITIONS FOR VIRAL PROTEASE INHIBITORS OF HEPATITIS C
ECSP067111A (en) DERIVATIVES OF PIRIDO-PIRIMIDINA, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS
PE106099A1 (en) USE OF SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMORAL AND ANTIMETASTASIC AGENTS
KR890002121A (en) Novel benzopyran derivatives, preparation method thereof and pharmaceutical composition containing the same
KR880012227A (en) New Use of Dopamine Receptor Antagonists
PE20020524A1 (en) 7-OXO-PYRIDOPYRIMIDINES AS KINASE INHIBITORS
AR010984A1 (en) NEW ESTERS OF PLEUROMUTILINE, AND THE ACID 1-AZABICICLO-4- CARBANILCARBANICO; PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE245157T1 (en) 3,9-DIAZABICYCLO-(3.3.1)-NONANYL DERIVATIVES, METHODS AND INTERMEDIATES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR053835A1 (en) TETRAHYDROPIRIDOAZEPIN - 8 - WAVES AS MODULATORS OF THE DOPAMINE D2 RECEIVER AND RELATED COMPOUNDS FOR THE TREATMENT OF SKISOPHRENIA AND OTHER SNC DISORDERS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THE PREPARATION OF MEDICATIONS.
AR015446A1 (en) ANTIGONISTS OF VITRONECTINE RECEPTORS, PHARMACEUTICAL COMPOSITION CONTAINING THEM, PROCEDURE FOR PREPARATION, ITS USE FOR THE PREPARATION OF A MEDICINE AND INTERMEDIATE COMPOUNDS
PE20071159A1 (en) DERIVATIVES OF TROPANE 3-MONOSUSTITUTED AS LIGANDS OF NOCICEPTIN RECEPTORS